Distinct impact of DMARD combination and monotherapy in immunogenicity of an inactivated SARS-CoV-2 vaccine in rheumatoid arthritis (2022)
- Authors:
- Medeiros-Ribeiro, Ana Cristina
- Bonfiglioli, Karina Rossi
- Domiciano, Diogo Souza
- Shimabuco, Andrea Yukie
- Silva, Henrique Carrico da
- Saad, Carla G. S.
- Yuki, Emily Figueiredo Neves
- Pasoto, Sandra Gofinet
- Araujo, Carlo Scognamiglio Renner
- Nakai, Tatiane Lie
- Silva, Clovis Artur Almeida da
- Kupa, Leonard de Vinci Kanda
- Kallas, Esper Georges
- Bonfa, Eloisa Silva Dutra de Oliveira
- USP affiliated authors: SILVA, CLOVIS ARTUR ALMEIDA DA - FM ; KUPA, LEONARD DE VINCI KANDA - FM ; KALLAS, ESPER GEORGES - FM ; BONFA, ELOISA SILVA DUTRA DE OLIVEIRA - FM
- Unidade: FM
- DOI: 10.1136/annrheumdis-2021-221735
- Subjects: FÁRMACOS DO SANGUE E SISTEMA HEMATOPOÉTICO; ESTUDOS PROSPECTIVOS; SISTEMA IMUNE
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Annals of the rheumatic diseases
- ISSN: 0003-4967
- Volume/Número/Paginação/Ano: v. 81, n. 5, p. 710-719, 2022
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
MEDEIROS-RIBEIRO, Ana Cristina et al. Distinct impact of DMARD combination and monotherapy in immunogenicity of an inactivated SARS-CoV-2 vaccine in rheumatoid arthritis. Annals of the rheumatic diseases, v. 81, n. 5, p. 710-719, 2022Tradução . . Disponível em: https://doi.org/10.1136/annrheumdis-2021-221735. Acesso em: 20 fev. 2026. -
APA
Medeiros-Ribeiro, A. C., Bonfiglioli, K. R., Domiciano, D. S., Shimabuco, A. Y., Silva, H. C. da, Saad, C. G. S., et al. (2022). Distinct impact of DMARD combination and monotherapy in immunogenicity of an inactivated SARS-CoV-2 vaccine in rheumatoid arthritis. Annals of the rheumatic diseases, 81( 5), 710-719. doi:10.1136/annrheumdis-2021-221735 -
NLM
Medeiros-Ribeiro AC, Bonfiglioli KR, Domiciano DS, Shimabuco AY, Silva HC da, Saad CGS, Yuki EFN, Pasoto SG, Araujo CSR, Nakai TL, Silva CAA da, Kupa L de VK, Kallas EG, Bonfa ESD de O. Distinct impact of DMARD combination and monotherapy in immunogenicity of an inactivated SARS-CoV-2 vaccine in rheumatoid arthritis [Internet]. Annals of the rheumatic diseases. 2022 ; 81( 5): 710-719.[citado 2026 fev. 20 ] Available from: https://doi.org/10.1136/annrheumdis-2021-221735 -
Vancouver
Medeiros-Ribeiro AC, Bonfiglioli KR, Domiciano DS, Shimabuco AY, Silva HC da, Saad CGS, Yuki EFN, Pasoto SG, Araujo CSR, Nakai TL, Silva CAA da, Kupa L de VK, Kallas EG, Bonfa ESD de O. Distinct impact of DMARD combination and monotherapy in immunogenicity of an inactivated SARS-CoV-2 vaccine in rheumatoid arthritis [Internet]. Annals of the rheumatic diseases. 2022 ; 81( 5): 710-719.[citado 2026 fev. 20 ] Available from: https://doi.org/10.1136/annrheumdis-2021-221735 - Thalidomide measurement in plasma and dried plasma spot by SPE combined with UHPLC-MS/MS for therapeutic drug monitoring
- SARS-CoV-2 vaccine in patients with systemic sclerosis: impact of disease subtype and therapy
- Impact of distinct therapies on antibody response to SARS-CoV-2 vaccine in systemic lupus erythematosus
- Immunogenicity, safety, and antiphospholipid antibodies after SARS-CoV-2 vaccine in patients with primary antiphospholipid syndrome
- Two-week methotrexate discontinuation in patients with rheumatoid arthritis vaccinated with inactivated SARS-CoV-2 vaccine: a randomised clinical trial
- Systemic autoimmune myopathies: a prospective phase 4 controlled trial of an inactivated virus vaccine against SARS-CoV-2
- Circulating Follicular Helper–Like T Cells in Systemic Lupus Erythematosus: Association With Disease Activity
- Lupus nephritis-related issues during COVID-19 pandemic quarantine
- Initial Benchmarking of the Quality of Medical Care in Childhood-Onset Systemic Lupus Erythematosus
- High rate of serious infection in juvenile idiopathic arthritis patients under biologic therapy in a real-life setting
Informações sobre o DOI: 10.1136/annrheumdis-2021-221735 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
